• Mon. Feb 26th, 2024

Revolutionizing Life Sciences: Depixus Wins Prestigious Ignite Award for MAGNA™ Technology


Feb 12, 2024
Depixus receives the Ignite Award at SLAS2024 for its MAGNA™ technology

Depixus, a pioneer in the field of interactomics, has been awarded the prestigious SLAS Ignite Award at the annual International Conference and Exhibition in Boston, MA. The company received this recognition for their groundbreaking MAGNA™ technology.

The Ignite Award is given to companies that are transforming the life sciences through their innovative technologies. The competition involved a panel of experts who evaluated participants based on various criteria including innovation excellence, marketing presence, impact, funding, and leadership balance. Out of 16 participating companies, Depixus was one of just eight selected as finalists for the award.

MAGNA One is an instrument that utilizes magnetic force spectroscopy to enable high-throughput analysis of dynamic biomolecular interactions. It is the first technology to provide real-time measurements from thousands of individual molecules simultaneously, making it an invaluable tool for exploring challenging targets such as RNA and protein-protein interactions. With this technology, Depixus provides valuable insights into disease mechanisms and accelerates the development of novel therapeutics.

Depixus CEO Gordon Hamilton expressed his excitement about winning the Ignite Award, highlighting the company’s innovative technology and its potential to impact the understanding and treatment of diseases where new treatments are urgently needed. Chief Commercial Officer Steve Klose added that this achievement coincides with the launch of their technology access program and commercial rollout of MAGNA One, marking a significant moment for Depixus.

For more information about Depixus and their MAGNA One technology, visit depixus.com or contact Steve Klose at steve.klose@depixus.com

Leave a Reply